Compare Fulford India with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs DIVIS LABORATORIES - Comparison Results

FULFORD INDIA     Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA DIVIS LABORATORIES FULFORD INDIA/
DIVIS LABORATORIES
 
P/E (TTM) x 398.8 32.6 1,222.5% View Chart
P/BV x 6.2 7.4 84.5% View Chart
Dividend Yield % 0.1 0.6 13.9%  

Financials

 FULFORD INDIA   DIVIS LABORATORIES
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
DIVIS LABORATORIES
Mar-18
FULFORD INDIA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs9421,142 82.5%   
Low Rs450533 84.4%   
Sales per share (Unadj.) Rs691.4146.6 471.6%  
Earnings per share (Unadj.) Rs11.533.0 34.7%  
Cash flow per share (Unadj.) Rs15.438.4 40.0%  
Dividends per share (Unadj.) Rs2.0010.00 20.0%  
Dividend yield (eoy) %0.31.2 24.1%  
Book value per share (Unadj.) Rs380.0222.8 170.5%  
Shares outstanding (eoy) m3.90265.47 1.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.05.7 17.6%   
Avg P/E ratio x60.725.3 239.6%  
P/CF ratio (eoy) x45.321.8 207.8%  
Price / Book Value ratio x1.83.8 48.7%  
Dividend payout %17.430.3 57.6%   
Avg Mkt Cap Rs m2,714222,318 1.2%   
No. of employees `0000.410.8 4.1%   
Total wages/salary Rs m5054,561 11.1%   
Avg. sales/employee Rs Th6,073.03,616.0 167.9%   
Avg. wages/employee Rs Th1,137.4423.8 268.4%   
Avg. net profit/employee Rs Th100.7814.9 12.4%   
INCOME DATA
Net Sales Rs m2,69638,915 6.9%  
Other income Rs m1251,134 11.1%   
Total revenues Rs m2,82240,049 7.0%   
Gross profit Rs m-4612,617 -0.4%  
Depreciation Rs m151,425 1.1%   
Interest Rs m1013 71.4%   
Profit before tax Rs m5412,313 0.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m103,543 0.3%   
Profit after tax Rs m458,770 0.5%  
Gross profit margin %-1.732.4 -5.3%  
Effective tax rate %17.728.8 61.4%   
Net profit margin %1.722.5 7.4%  
BALANCE SHEET DATA
Current assets Rs m1,73845,351 3.8%   
Current liabilities Rs m5456,507 8.4%   
Net working cap to sales %44.399.8 44.3%  
Current ratio x3.27.0 45.8%  
Inventory Days Days48127 38.3%  
Debtors Days Days495 4.5%  
Net fixed assets Rs m1221,160 0.1%   
Share capital Rs m39531 7.3%   
"Free" reserves Rs m1,44358,625 2.5%   
Net worth Rs m1,48259,156 2.5%   
Long term debt Rs m00-   
Total assets Rs m2,07767,832 3.1%  
Interest coverage x6.7926.8 0.7%   
Debt to equity ratio x00-  
Sales to assets ratio x1.30.6 226.3%   
Return on assets %2.612.9 20.2%  
Return on equity %3.014.8 20.3%  
Return on capital %4.320.8 20.7%  
Exports to sales %00-   
Imports to sales %24.521.8 112.1%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m6598,485 7.8%   
Fx inflow Rs m1732,359 0.1%   
Fx outflow Rs m6739,042 7.4%   
Net fx Rs m-65623,317 -2.8%   
CASH FLOW
From Operations Rs m907,759 1.2%  
From Investments Rs m105-4,783 -2.2%  
From Financial Activity Rs m-14-3,142 0.4%  
Net Cashflow Rs m181-166 -108.7%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 11.8 32.2%  
FIIs % 0.1 19.0 0.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 17.2 123.3%  
Shareholders   4,783 31,796 15.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   J.B.CHEMICALS  VENUS REMEDIES  STERLING BIOTECH  WOCKHARDT  AUROBINDO PHARMA  

Compare FULFORD INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY19); Net Profit Up 10.6% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 10.6% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (3QFY19); Net Profit Up 68.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 68.9% YoY). Sales on the other hand came in at Rs 13 bn (up 29.4% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (2QFY19); Net Profit Up 92.3% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 92.3% YoY). Sales on the other hand came in at Rs 13 bn (up 44.3% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS